# Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)

> **NCT01947309** · — · TERMINATED · sponsor: **Celgene** · enrollment: 176 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Revlimid (lenalidomide)

## Key facts

- **NCT ID:** NCT01947309
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 176 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01947309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01947309, "Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01947309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*